We are live on ! Find out more
MTNB icon

Matinas BioPharma
MTNB

28 hedge funds and large institutions have $618K invested in Matinas BioPharma in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 1

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

143% more capital invested

Capital invested by funds: $254K → $618K (+$364K)

17% more funds holding

Funds holding: 24 → 28 (+4)

1.06% more ownership

Funds ownership: 5.43% → 6.49% (+1.1%)

Holders
28
Holders Change
+4
Holders Change %
+16.67%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
+$32.5K
2
TSS
Two Sigma Securities
New York
+$18.1K
3
HF
HRT Financial
New York
+$15.5K
4
Renaissance Technologies
Renaissance Technologies
New York
+$5.17K
5
Citigroup
Citigroup
New York
+$1.81K

Top Sellers

Rank Fund Capital Flow
1
Raymond James Financial
Raymond James Financial
Florida
-$285
2
Bank of America
Bank of America
North Carolina
-$4
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$113K – – –
Geode Capital Management
2
Geode Capital Management
Massachusetts
$106K +$684 +476 +0.9%
BlackRock
3
BlackRock
New York
$93.8K – – –
SIG
4
Sargent Investment Group
Maryland
$69.2K +$1.44K +1,000 +3%
HIW
5
Holos Integrated Wealth
Pennsylvania
$55.5K – – –
Renaissance Technologies
6
Renaissance Technologies
New York
$53.4K +$5.17K +3,600 +15%
Northern Trust
7
Northern Trust
Illinois
$42.7K +$32.5K +22,594 New
State Street
8
State Street
Massachusetts
$29K – – –
TSS
9
Two Sigma Securities
New York
$23.7K +$18.1K +12,560 New
HF
10
HRT Financial
New York
$20K +$15.5K +10,784 New
TRCT
11
Tower Research Capital (TRC)
New York
$2.73K +$494 +344 +31%
Citigroup
12
Citigroup
New York
$2.38K +$1.81K +1,260 New
Bank of America
13
Bank of America
North Carolina
$1.85K -$4 -3 -0.3%
Morgan Stanley
14
Morgan Stanley
New York
$1.06K +$599 +417 +290%
Rockefeller Capital Management
15
Rockefeller Capital Management
New York
$945 +$719 +500 New
FFA
16
Farther Finance Advisors
California
$798 +$599 +417 +8,340%
Osaic Holdings
17
Osaic Holdings
Arizona
$394 – – –
CAM
18
Costello Asset Management
Pennsylvania
$378 – – –
UBS Group
19
UBS Group
Switzerland
$378 +$129 +90 +82%
Wells Fargo
20
Wells Fargo
California
$193 – – –
SPIA
21
Steward Partners Investment Advisory
New York
$115 – – –
Jones Financial Companies
22
Jones Financial Companies
Missouri
$114 – – –
EWA
23
EverSource Wealth Advisors
Alabama
$113 – – –
VFM
24
Vision Financial Markets
Connecticut
$76 – – –
RIL
25
Rothschild Investment LLC
Illinois
$26 – – –
1
2

MTNB Hedge Fund Activity: Q3 2025 in Review

28 of the 7,629 institutional investors tracked by Wall St. Rank reported a position in Matinas BioPharma (MTNB) for Q3 2025, worth a combined $618K — up 143% from $254K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new MTNB positions and 1 closed out — a net gain of 4 holders — while 8 added to existing stakes and 1 trimmed.

The largest buyer was Northern Trust, opening a new position worth an estimated $32.5K. The largest seller was Raymond James Financial, exiting entirely with an estimated $285 sold.

  • 28 institutional investors held Matinas BioPharma (MTNB) as of Q3 2025, up from 24 in Q2 2025.
  • Funds reported $618K of Matinas BioPharma stock for Q3 2025, up 143% quarter-over-quarter.
  • 5 funds opened new Matinas BioPharma positions in Q3 2025 and 1 closed out, a net change of +4 holders.
  • The largest Matinas BioPharma buyer in Q3 2025 was Northern Trust, an estimated $32.5K added.
  • The largest Matinas BioPharma seller in Q3 2025 was Raymond James Financial, an estimated $285 sold.

Based on aggregated 13F filings for Q3 2025.